TrialThe New England journal of medicine2023
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
Zhujun Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
102 papers cite itlatest 60 shown
this paperpooled ittrialcites it